Cargando…
Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke
Acute stroke management is critically time-sensitive and challenging. Blood-based biomarkers that can differentiate acute ischemic stroke (IS) from hemorrhagic stroke (HS) can greatly facilitate triage and early management. Admission blood samples obtained within 6 h of stroke symptom onset were ana...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486392/ https://www.ncbi.nlm.nih.gov/pubmed/37685295 http://dx.doi.org/10.3390/diagnostics13172757 |
_version_ | 1785102995693764608 |
---|---|
author | Han, Eunhee Kim, Hyejeong Cho, Bongrae Lee, Jeong-Joong Shin, Soyoung Oh, Eun-Jee Chae, Hyojin |
author_facet | Han, Eunhee Kim, Hyejeong Cho, Bongrae Lee, Jeong-Joong Shin, Soyoung Oh, Eun-Jee Chae, Hyojin |
author_sort | Han, Eunhee |
collection | PubMed |
description | Acute stroke management is critically time-sensitive and challenging. Blood-based biomarkers that can differentiate acute ischemic stroke (IS) from hemorrhagic stroke (HS) can greatly facilitate triage and early management. Admission blood samples obtained within 6 h of stroke symptom onset were analyzed in a derivation/validation design. GFAP, N-FL, NT-proBNP, copeptin, neutrophils (%), NLR, and platelet counts were assessed in the derivation cohort. The informative markers and the derived cutoff values were evaluated in the validation cohort. GFAP > 703 pg/mL showed a PPV of 76.9% and NPV of 95.8% for differentiating HS from IS. Multiple logistic regression analysis showed that GFAP and NT-proBNP were independent variables associated with IS and HS differentiation. Furthermore, applying a combined cutoff (GFAP > 703 pg/mL and NT-proBNP ≤ 125 pg/mL) for HS detection increased the PPV in both the derivation and validation cohorts (93.3% and 100%, respectively). GFAP and NT-proBNP levels were validated as informative blood biomarkers in the differentiation of IS and HS and using a combination of GFAP and NT-proBNP is suggested as a feasible strategy to differentiate stroke subtypes in the hyperacute phase of stroke. |
format | Online Article Text |
id | pubmed-10486392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104863922023-09-09 Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke Han, Eunhee Kim, Hyejeong Cho, Bongrae Lee, Jeong-Joong Shin, Soyoung Oh, Eun-Jee Chae, Hyojin Diagnostics (Basel) Article Acute stroke management is critically time-sensitive and challenging. Blood-based biomarkers that can differentiate acute ischemic stroke (IS) from hemorrhagic stroke (HS) can greatly facilitate triage and early management. Admission blood samples obtained within 6 h of stroke symptom onset were analyzed in a derivation/validation design. GFAP, N-FL, NT-proBNP, copeptin, neutrophils (%), NLR, and platelet counts were assessed in the derivation cohort. The informative markers and the derived cutoff values were evaluated in the validation cohort. GFAP > 703 pg/mL showed a PPV of 76.9% and NPV of 95.8% for differentiating HS from IS. Multiple logistic regression analysis showed that GFAP and NT-proBNP were independent variables associated with IS and HS differentiation. Furthermore, applying a combined cutoff (GFAP > 703 pg/mL and NT-proBNP ≤ 125 pg/mL) for HS detection increased the PPV in both the derivation and validation cohorts (93.3% and 100%, respectively). GFAP and NT-proBNP levels were validated as informative blood biomarkers in the differentiation of IS and HS and using a combination of GFAP and NT-proBNP is suggested as a feasible strategy to differentiate stroke subtypes in the hyperacute phase of stroke. MDPI 2023-08-25 /pmc/articles/PMC10486392/ /pubmed/37685295 http://dx.doi.org/10.3390/diagnostics13172757 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Han, Eunhee Kim, Hyejeong Cho, Bongrae Lee, Jeong-Joong Shin, Soyoung Oh, Eun-Jee Chae, Hyojin Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke |
title | Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke |
title_full | Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke |
title_fullStr | Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke |
title_full_unstemmed | Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke |
title_short | Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke |
title_sort | plasma glial fibrillary acidic protein and n-terminal pro b-type natriuretic peptide: potential biomarkers to differentiate ischemic and hemorrhagic stroke |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486392/ https://www.ncbi.nlm.nih.gov/pubmed/37685295 http://dx.doi.org/10.3390/diagnostics13172757 |
work_keys_str_mv | AT haneunhee plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke AT kimhyejeong plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke AT chobongrae plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke AT leejeongjoong plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke AT shinsoyoung plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke AT oheunjee plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke AT chaehyojin plasmaglialfibrillaryacidicproteinandnterminalprobtypenatriureticpeptidepotentialbiomarkerstodifferentiateischemicandhemorrhagicstroke |